Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ce |
RCV001092666 | SCV001249279 | uncertain significance | not provided | 2019-10-01 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001856273 | SCV002315206 | benign | Norman-Roberts syndrome; Familial temporal lobe epilepsy 7 | 2023-08-10 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004031988 | SCV004937392 | uncertain significance | Inborn genetic diseases | 2023-11-17 | criteria provided, single submitter | clinical testing | The c.1789C>T (p.H597Y) alteration is located in exon 15 (coding exon 15) of the RELN gene. This alteration results from a C to T substitution at nucleotide position 1789, causing the histidine (H) at amino acid position 597 to be replaced by a tyrosine (Y). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |